Trials / Completed
CompletedNCT00850681
A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
A Randomized, Controlled Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers Using an Open Application Photoallergic Test Design
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Peplin · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEP005 (ingenol mebutate) Gel | PEP005 (ingenol mebutate) Gel, 0.01% |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2009-02-25
- Last updated
- 2015-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00850681. Inclusion in this directory is not an endorsement.